There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

The differential diagnoses for CRCC include RCC with cystic change, hereditary leiomyomatosis manifesting as a cystic renal lesion, cystic nephroma, clear ... Cystic renal cell carcinoma is ...

Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune response, offering new ...

During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Chronic obstructive pulmonary disease (COPD) is a major cause of death among patients with renal cell carcinoma (RCC) in the United States, investigators reported at ASCO’s 2025 Genitourinary Cancers ...

GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

currently an assistant professor at Cold Spring Harbor Laboratory have found a possible source of this variability in clear cell renal cell carcinoma (ccRCC)-;the most common kidney cancer ...

mRCC, metastatic renal cell carcinoma; OS, overall survival; PFS, progression-free survival. Primary insurance status was categorized into three groups—patients with Medicare, private insurance, and ...